[Two new oral disease modifying therapies in relapsing remitting multiple sclerosis]

Rev Neurol (Paris). 2014 Dec;170(12):721-2. doi: 10.1016/j.neurol.2014.11.002.
[Article in French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Administration, Oral
  • Crotonates / administration & dosage*
  • Crotonates / adverse effects
  • Dimethyl Fumarate
  • Fumarates / administration & dosage*
  • Fumarates / adverse effects
  • Humans
  • Hydroxybutyrates
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Nitriles
  • Therapies, Investigational*
  • Toluidines / administration & dosage*
  • Toluidines / adverse effects
  • Treatment Outcome

Substances

  • Crotonates
  • Fumarates
  • Hydroxybutyrates
  • Nitriles
  • Toluidines
  • teriflunomide
  • Dimethyl Fumarate